Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HLCS | P50747 | 1/20 | 0.35 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4615754 | 0.98 | HLCS (0.37) | HLCSPPARGHTTCYP1A2 | |
| SCHEMBL4616362 | 0.94 | HTT (0.33) | PPARGHTTCYP1A2 | |
| SCHEMBL9999670 | 0.90 | CYP1A2 (0.37) | PPARGHTTCYP1A2 | |
| SCHEMBL17227787 | 0.88 | CYP1A2 (0.40) | PPARGHTTCYP1A2 | |
| SCHEMBL491015 | 0.86 | — | — | |
| SCHEMBL2272354 | 0.81 | CYP1A2 (0.51) | PPARGCYP1A2 | |
| SCHEMBL23795751 | 0.80 | HTT (0.46) | PPARGHTT | |
| SCHEMBL22187096 | 0.80 | ABHD16A (0.38) | PPARGHTTCYP1A2 | |
| SCHEMBL16339694 | 0.79 | CYP1A2 (0.35) | PPARGCYP1A2 | |
| SCHEMBL9576975 | 0.79 | CYP1A2 (0.54) | PPARGCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400537-A1 | FOAMING AGENT COMPOSITION FOR POLYURETHANE AND METHOD OF PREPARING POLYURETHANE FOAM USING SAME | Seho Inc. (KR) | 2024-07-17 | — | — | EP | disclosed |
| CN-118344641-A | Blowing agent composition for polyurethane and method for preparing polyurethane foam using the same | 世好 | 2024-07-16 | — | — | CN | disclosed |
| US-20230002540-A1 | FOAMED POLYURETHANE COMPOSITIONS | PRESIDIUM INNOVATIONS, LLC | 2023-01-05 | — | — | US | disclosed |
| WO-2021222192-A1 | POLYURETHANE COMPOSITIONS | PRESIDIUM USA, INC. (US) | 2021-11-04 | — | — | WO | disclosed |
| CN-108715723-B | Electrocoating compositions containing anticrater agent | 涂层国外知识产权有限公司 | 2021-11-02 | — | — | CN | disclosed |
| US-10577510-B2 | Electrocoating composition including an anti-crater agent | Axalta Coating Systems IP Co. LLC (US) | 2020-03-03 | — | — | US | disclosed |
| US-20180282557-A1 | ELECTROCOATING COMPOSITON INCLUDING AN ANTI-CRATER AGENT | AXALTA COATING SYSTEMS IP CO., LLC (US) | 2018-10-04 | — | — | US | disclosed |
| US-7544794-B1 | Method for sequencing DNA and RNA by synthesis | BENNER STEVEN ALBERT | 2009-06-09 | — | — | US | disclosed |
| EP-1831317-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING AN ANTI-CRATER AGENT | DU PONT (US) | 2008-03-05 | — | — | EP | disclosed |
| EP-1819782-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING AN ANTI-CRATER AGENT | DU PONT (US) | 2008-03-05 | — | — | EP | disclosed |
| US-7264706-B2 | Cathodic electrocoating compositions containing an anti-crater agent | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-7264705-B2 | Cathodic electrocoating compositions containing an anti-crater agent | E. I. DUPONT DE NEMOURS AND COMPANY (US) | 2007-09-04 | — | — | US | disclosed |
| US-20060084725-A1 | Cathodic electrocoating compositions containing an anti-crater agent | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2006-04-20 | — | — | US | disclosed |
| US-20060084726-A1 | Cathodic electrocoating compositions containing an anti-crater agent | AXALTA COATING SYSTEMS IP CO. LLC (FORMERLY KNOWN AS U.S. COATINGS IP CO. LLC) | 2006-04-20 | — | — | US | disclosed |
| EP-1425354-B1 | CATHODIC ELECTROCOATING COMPOSITIONS CONTAINING HYDROXYL-CARBONATE BLOCKED POLYISOCYANATE CROSSLINKING AGENT | DU PONT (US) | 2005-03-16 | — | — | EP | disclosed |
| US-6825361-B2 | EPOXY-AMINE ADDUCTS; ELECTRODEPOSITED FINISHES WITH REDUCED WEIGHT LOSS WHEN HEATED TO CURE | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-11-30 | — | — | US | disclosed |
| US-20040084313-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | PALADIN PHARMA INC. (CA) | 2004-05-06 | — | — | US | disclosed |
| US-6607646-B2 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-08-19 | — | — | US | disclosed |
| US-20030064227-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-04-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030064227-A1 | Cathodic electrocoating compositions containing hydroxyl-carbonate blocked polyisocyanate crosslinking agent | TET2, TET1, HAAO | HLCS 533/4885PPARG 3377/4885HTT 546/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.